# OnCo record transgene (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/transgene/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "transgene" ;
  schema:name "Transgene"@en ;
  schema:description "Transgene uses modified viruses to make cancer immunotherapies. Its lead product is a personalised vaccine built from each patient's tumour mutations, given after surgery to stop head and neck cancer coming back."@en ;
  schema:url <https://onco.cc/companies/transgene/>, <https://www.transgene.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.transgene.com/>, <https://www.transgene.com/wp-content/uploads/Transgene_PR_Results_EN.pdf>, <https://www.transgene.com/wp-content/uploads/20260902_TG4050_NatCom_EN.pdf> ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/neoantigen-mrna-vaccine/>, <https://onco.cc/technologies/oncolytic-virus/> ;
  onco:trials <https://onco.cc/trials/nct03260023/>, <https://onco.cc/trials/nct04183166/> .